MedPath

A Telephone Intervention to Improve Participation in a Screening Program.

Not Applicable
Completed
Conditions
Colorectal Cancer
Colorectal Neoplasms
Registration Number
NCT03082911
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

Objective: To assess the effectiveness of a brief telephone intervention added to an post invitation letter in the participation rate to a colorectal cancer screening program.

Methods: Randomized controlled trial. This study is framed inside the colorectal cancer screening program of Catalonia, concretely in the region of Vallès Occidental. This program is directed to men and women from 50 to 69 years. The screening test used is the fecal immunological test (FIT) that is offered every 2 years. If the screening test is positive, a colonoscopy with sedation is offered as a diagnostic test.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
432
Inclusion Criteria
  • Women and men from 50 to 69 years living in the selected territories (Terrassa C, Terrassa A, Cerdanyola del Vallès 1) that will be invited for the first time in the Colorectal cancer screening program.
Exclusion Criteria
  • The same as those used in the population program:

    1. History of colorectal cancer;

    2. History of inflammatory bowel disease;

    3. history of colorectal adenomas;

    4. family history of polyposis syndromes or hereditary nonpolyposis colorectal cancer;

    5. family history of colorectal cancer if: two first grade relatives affected or only one fist grade relative affected diagnosed before the age of 60;

    6. terminal illness or severe disability which contraindicates the study of the colon. People is excluded temporally if:

        1. they have a colonoscopy performed in the last 5 years;
        1. present digestive signs or symptoms (rectal bleeding, change in bowel habits, abdominal pain, weight loss with fatigue and anorexia, abdominal mass);
        1. they express the will to be out of the Program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Participation6 months

Participation is defined as the number of people who do the screening test to the total of people invited to the Program.

Secondary Outcome Measures
NameTimeMethod
Knowledge of the program1 day at the time of intervention administration

proportion of people from the intervention group who report knowing the existence of the program.

Comprehension of the information received1 day at the time of intervention administration

proportion of people from the intervention group who report having understood in which the screening program consists of.

Help to decide about participation1 day at the time of intervention administration

proportion of people from the intervention group who report that the information received in the phone call will be useful to decide about their participation in the program.

Trial Locations

Locations (1)

Corporació Sanitària Parc Taulí

🇪🇸

Sabadell, Barcelona, Spain

Corporació Sanitària Parc Taulí
🇪🇸Sabadell, Barcelona, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.